These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 12618899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations.
    Molnár I, Kute T, Willingham MC, Schwartz GG.
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):539-43. PubMed ID: 15225834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M, Uskokovic M, Hisatake J, Hisatake Y, Koike K, Komiyama A, Koeffler HP.
    Cancer Res; 2001 Apr 15; 61(8):3361-8. PubMed ID: 11309293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
    Huang Q, Wang L, Ran Q, Wang J, Wang C, He H, Li L, Qi H.
    Drug Des Devel Ther; 2019 Apr 15; 13():1927-1940. PubMed ID: 31239643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J, O'Kelly J, Uskokovic MR, Tomoyasu S, Koeffler HP.
    Blood; 2001 Apr 15; 97(8):2427-33. PubMed ID: 11290607
    [Abstract] [Full Text] [Related]

  • 10. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP.
    Blood; 1998 Oct 01; 92(7):2441-9. PubMed ID: 9746784
    [Abstract] [Full Text] [Related]

  • 11. Differentiation and apoptosis of U-937 leukemia cells by an active compound from Dendrostellera lessertii.
    Meshkini A, Yazdanparast R, Haidari M.
    Iran Biomed J; 2009 Jan 01; 13(1):35-42. PubMed ID: 19252676
    [Abstract] [Full Text] [Related]

  • 12. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
    Kumagai T, Shih LY, Hughes SV, Desmond JC, O'Kelly J, Hewison M, Koeffler HP.
    Cancer Res; 2005 Mar 15; 65(6):2488-97. PubMed ID: 15781666
    [Abstract] [Full Text] [Related]

  • 13. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
    Ikezoe T, Chen S, Saito T, Asou H, Kyo T, Tanosaki S, Heber D, Taguchi H, Koeffler HP.
    Int J Oncol; 2003 Oct 15; 23(4):1203-11. PubMed ID: 12964005
    [Abstract] [Full Text] [Related]

  • 14. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP.
    Cancer Res; 1996 Aug 01; 56(15):3570-6. PubMed ID: 8758928
    [Abstract] [Full Text] [Related]

  • 15. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
    Huang SM, Yang JS, Tsai SC, Chen MH, Hsu MH, Lin HY, Chou LC, Chinag JH, Lee KH, Huang LJ, Kuo SC.
    Int J Oncol; 2011 May 01; 38(5):1357-64. PubMed ID: 21344160
    [Abstract] [Full Text] [Related]

  • 16. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
    Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M.
    Nutr Cancer; 2001 May 01; 41(1-2):135-44. PubMed ID: 12094616
    [Abstract] [Full Text] [Related]

  • 17. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K, Miyazawa K, Yaguchi M, Gotoh A, Ohyashiki K.
    Leukemia; 2002 Aug 01; 16(8):1519-27. PubMed ID: 12145693
    [Abstract] [Full Text] [Related]

  • 18. [Effects of arsenic trioxide and ATRA on PLZF-RARalpha-positive U937 leukemic cells].
    Chen SY, Ma LH, Dong Y, Guo WJ, Wang ZY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep 01; 23(9):824-6. PubMed ID: 17825229
    [Abstract] [Full Text] [Related]

  • 19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 01; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 20. Effect of valproic acid and antiapoptotic cytokines on differentiation and apoptosis induction of human leukemia cells.
    Rezácová M, Vávrová J, Vokurková D, Záskodová D.
    Gen Physiol Biophys; 2006 Mar 01; 25(1):65-79. PubMed ID: 16714776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.